Takeda receives clearance from EC for proposed acquisition of Shire

Takeda has announced that it has received clearance from the European Commission for the proposed acquisition of Shire a...

November 22, 2018 | Thursday | News
Alvotech, Fuji Pharma partner for biosimilars

Alvotech and Fuji Pharma has announced that the two companies are entering into an exclusive partnership for the commerc...

November 20, 2018 | Tuesday | News
Mundipharma to bring world's first gene therapy for knee osteoarthritis

In a multi-year agreement for up to USD 600 million, Mundipharma has acquired the exclusive rights for Invossa in Japan ...

November 19, 2018 | Monday | News
Karl Deisseroth receives Japan’s Kyoto prize in advanced technology

The Inamori Foundation has announced that it has presented its 34th annual Kyoto Prize in Advanced Technology to Dr. Kar...

November 19, 2018 | Monday | News
HeartFlow receives reimbursement approval in Japan

HeartFlow, Inc. has announced that the Japanese Ministry of Health, Labor and Welfare (MHLW) has approved the recommenda...

November 19, 2018 | Monday | News
Takeda sets target date to close $62B Shire deal

Singapore – Aiming to close its deal for Shire on Jan. 8, Japanese drugmaker, Takeda Pharmaceutical will ...

November 12, 2018 | Monday | News
Philips, Allm to develop mobile diagnostic solutions

Royal Philips, a global leader in health technology, has announced a collaboration with Japanese healthcare informatics ...

November 12, 2018 | Monday | News
Japan conducts world’s first iPS cell transplant for Parkinson’s

A research team from Kyoto University, Japan has conducted the world’s first transplant of induced pluripotent ste...

November 10, 2018 | Saturday | News
MEI Pharma, KHK to develop and commercialize ME-401

MEI Pharma, Inc. and Kyowa Hakko Kirin Co., Ltd. (KHK), have announced the execution of a license agreement granting KHK...

November 5, 2018 | Monday | News
HKSTP showcases Hong Kong's Innovation and Technology edge

Hong Kong Science and Technology Parks Corporation (HKSTP) announced its fruitful participation in promoting Hong K...

November 2, 2018 | Friday | News
Kissei buys exclusive rights of Tavalisse in Asian countries

Japanese drugmaker Kissei Pharmaceutical has acquired exclusive rights to develop and commercialize Tavalisse (fostamati...

November 1, 2018 | Thursday | News
Green Science Alliance starts production of Chitin, Chitosan Nanofiber

Chitin nanofiber is a new material made from crab shells. In brief, it can be prepared by making chitin on a nanoscale. ...

October 30, 2018 | Tuesday | News
Mitsui Chemicals, Chitose Group launch novel open innovation initiative

Mitsui Chemicals, Inc. and Chitose Group, a group of biotechnology startups have jointly launched the "0 to 1 Project" a...

October 30, 2018 | Tuesday | News
NEC, Transgene collaborate for individualized cancer immunotherapy

NEC Corporation and Transgene have announced the signing of a Memorandum of Understanding (MoU) for a strategic collabor...

October 30, 2018 | Tuesday | News
Daiichi enters clinical collaboration with Merck, Pfizer

Daiichi Sankyo Company, Limited announced that it has entered into a clinical trial collaboration agreement with Merck K...

October 27, 2018 | Saturday | News
Mesoblast licensee seeks expanded indication for stem cell product in Japan

Singapore –  Mesoblast announces that Japanese licensee JCR Pharmaceuticals Co. Ltd. plans to seek a new...

October 24, 2018 | Wednesday | News
J & J announces Offer to Acquire Ci:z Holdings Co., Ltd.

Johnson & Johnson has announced that they have agreed with Ci:z Holdings Co., Ltd. a Japanese company focused on the...

October 23, 2018 | Tuesday | News
Eisai, MSD start marketing activity for LENVIMA

Eisai Co., Ltd. and MSD K.K., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A., have announced that the t...

October 23, 2018 | Tuesday | News